Orchestra BioMed Holdings, Inc. (OBIO)
NASDAQ: OBIO · Real-Time Price · USD
3.940
+0.230 (6.20%)
At close: Feb 6, 2026, 4:00 PM EST
3.910
-0.030 (-0.76%)
After-hours: Feb 6, 2026, 4:04 PM EST
Orchestra BioMed Holdings Market Cap
Orchestra BioMed Holdings has a market cap or net worth of $222.47 million as of February 6, 2026. Its market cap has increased by 6.21% in one year.
Market Cap
222.47M
Enterprise Value
140.99M
1-Year Change
6.21%
Ranking
Category
Stock Price
$3.94
Market Cap Chart
Since August 4, 2020, Orchestra BioMed Holdings's market cap has increased from $197.44M to $222.47M, an increase of 12.68%. That is a compound annual growth rate of 2.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 220.78M | -5.78% |
| Dec 31, 2025 | 234.33M | 54.11% |
| Dec 31, 2024 | 152.05M | -53.41% |
| Dec 29, 2023 | 326.34M | 191.65% |
| Dec 30, 2022 | 111.90M | -45.72% |
| Dec 31, 2021 | 206.14M | -21.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Aug 4, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Climb Bio | 222.01M |
| Heron Therapeutics | 221.87M |
| MediWound | 220.72M |
| Nuvectis Pharma | 216.45M |
| Inhibikase Therapeutics | 216.12M |
| Silence Therapeutics | 213.50M |
| Achieve Life Sciences | 210.27M |
| Context Therapeutics | 207.65M |